All stock lists
Lennox International Inc (New York Stock Exchange:LII)
US · Delayed Price · Currency is USD
Industrials · Industrial - Machinery
344.08-4.04 (-1.16%)
Market cap
$11.8B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 29, 1999
Website
Insider Score
––Not scored
LII Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
LII analyst forecast
LII analyst consensus
Hold8 ratings
Buy 0 Hold 7 Sell 1
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
LII 12-month price target
$364.50+5.9% upsideaverage of 4 firms
$378.00High
$350.00Low
LII ratings mix, last 12 months
Buy Hold Sell
Best analysts covering LII
- Morgan Stanley75%success rate · +11.7% avg return · 4 calls
- JP Morgan71%success rate · +5.9% avg return · 7 calls
- Goldman Sachs50%success rate · -1.2% avg return · 6 calls
- Barclays0%success rate · -18.3% avg return · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
LII analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | BNP Paribas | Neutral | — | — | Reiterated | 2026-10-30 |
| RBC Capital | Sector Perform | $378.00 | +12.6% | Reiterated | 2026-10-29 | |
| — | Oppenheimer | Perform | — | — | Downgraded | 2026-10-29 |
| Wells Fargo | Equal Weight | $355.00 | +5.5% | Reiterated | 2026-10-29 | |
| Mizuho Securities | — | $350.00 | +5.2% | — | 2026-10-29 | |
| — | Morgan Stanley | Underweight | — | — | Reiterated | 2026-10-15 |
| Mizuho | Neutral | $395.00 | +13.2% | Reiterated | 2026-10-15 | |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-10-14 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-10-14 |
| — | Goldman Sachs | Neutral | — | — | Downgraded | 2026-10-14 |
| Wells Fargo | — | $424.00 | +15.3% | — | 2026-09-24 | |
| — | Deutsche Bank | Hold | — | — | Downgraded | 2026-09-14 |
| Morgan Stanley | Underweight | $375.00 | -0.4% | Reiterated | 2026-09-03 | |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-07-31 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-07-30 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-04-30 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-04-30 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-30 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-01 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-04-01 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-03-05 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-03-05 |
| — | Morgan Stanley | Underweight | — | — | Reiterated | 2026-02-02 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-01-29 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-01-29 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2026-01-16 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-01-07 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-12-11 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-12-04 |
| — | Wolfe Research | Peer Perform | — | — | Upgraded | 2025-11-13 |
| — | UBS | Neutral | — | — | Reiterated | 2025-10-27 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-10-23 |
| — | Morgan Stanley | Underweight | — | — | Reiterated | 2025-10-23 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-10-23 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2025-10-23 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2025-10-23 |
| — | Mizuho | Neutral | — | — | Reiterated | 2025-10-17 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2025-10-15 |
| — | Wells Fargo | Equal Weight | — | — | Upgraded | 2025-10-06 |
| — | UBS | Neutral | — | — | Reiterated | 2025-09-23 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-09-17 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-09-16 |
| — | UBS | Neutral | — | — | Reiterated | 2025-07-28 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-07-24 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-07-24 |
| — | Wells Fargo | Underweight | — | — | Reiterated | 2025-07-24 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-07-17 |
| — | Baird | Neutral | — | — | Reiterated | 2025-07-17 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-07-08 |
| — | Wells Fargo | Underweight | — | — | Reiterated | 2025-07-01 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2025-05-16 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-04-24 |
| — | Wells Fargo | Underweight | — | — | Reiterated | 2025-04-24 |
| — | Baird | Neutral | — | — | Reiterated | 2025-04-24 |
| — | Morgan Stanley | Underweight | — | — | Reiterated | 2025-04-24 |
| — | UBS | Neutral | — | — | Reiterated | 2025-04-24 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2025-04-24 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2025-04-08 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-03-07 |
| — | Barclays | Overweight | — | — | Upgraded | 2025-02-26 |
LII earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-01-28 | 4.75 | 4.45 | $1.27B | $1.20B |
| 2026-04-29 | 3.19 | 3.35 | $1.07B | $1.14B |
| 2026-07-29 | 7.67 | 7.72 | $1.56B | $1.55B |
| 2026-10-28 | 7.29 | 6.84 | $1.57B | $1.57B |
| 2027-01-27Upcoming | 3.74 | — | $1.24B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.